J Bryce, M Bauer… - Oncology Nursing Forum, 2011 - Onc Nurs Society ... planned duration of five years. herapy was initi- . herapy was initi- herapy was initi- ated after a dental examination to assess risk factors for osteonecrosis of the jaw, which yielded no pathology. he poten- tial side effects ... Related articles - All 2 versions
LR Guterman… - The Carotid and Supra‐Aortic …, 2011 - Wiley Online Library Page 1. 412 Endovascular t herapy for a cute s troke Lee R. Guterman, 1 Eve A. Guterman 2 1Catholic Health System and Buffalo Neurosurgery Group, Buffalo, NY, USA 2Barnard College, Columbia University, New York, NY, USA Introduction ... Related articles
[PDF] from scielo.brF Amarante, LC Vilodre, MA Maturana… - Brazilian Journal of …, 2011 - SciELO Brasil ... Twen y seven (84.4%) POI women were receivin hormone replacemen herapy ( RT) a he ime of he s udy. ... In he pos menopausal reference roup 17 women (30.4%) were curren users of hormone herapy. ... Related articles - All 4 versions
EA Perez - The Oncologist, 2011 - AlphaMed Press ... The Genomic Era of Targeted Therapy. Before the widespread use of genomics for prognostic and therapeutic applications, the traditional measures of recurrence risk included tumor size and tumor grade, as well as disease state and age. ... All 2 versions
[PDF] from biomedcentral.comC Tapp, MJ Milloy, T Kerr, R Zhang… - BMC infectious …, 2011 - biomedcentral.com ... Page 2. Page 1 of 22 Female gender predicts lower access and ccess and ccess and adherence to dherence to antiretroviral ntiretroviral ntiretroviral therapy in a herapy in a herapy in a setting of etting of etting of free healthcare ealthcare ealthcare ... Cited by 1 - Related articles - View as HTML - All 6 versions